Intergroup comparison | Intragroup comparison | Â | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Variable | Non-adherence criteria | Stage | Group | f (%) | Mann-Whitney U | Group | Wilcoxon Signed Ranks | Â | ||
Z | p | Z | p | Â | ||||||
IDWG (Kg) | > 5.7% of dry weight | Before | mHealth | 13 (37.1) | -1.89 | 0.058 | mHealth | -3.60 | < 0.0001 |  |
Face-to-Face | 21 (60.0) | Â | ||||||||
After | mHealth | 0 (0.0) | -2.98 | 0.003 | Face-to-Face | -3.60 | < 0.0001 |  | ||
Face-to-Face | 8 (22.8) | Â | ||||||||
K (mmol/l) | > 6 | Before | mHealth | 2 (5.7) | -1.42 | 0.154 | mHealth | -1.41 | 0.157 |  |
Face-to-Face | 0 (0.0) | Â | ||||||||
After | mHealth | 0 (0.0) | 0.00 | 1.00 | Face-to-Face | 0.00 | 1.00 | Â | ||
Face-to-Face | 0 (0.0) | Â | ||||||||
TC (mg/dl) | > 200 | Before | mHealth | 19 (54.2) | -0.48 | 0.632 | mHealth | -2.98 | 0.003 |  |
Face-to-Face | 21 (60.0) | Â | ||||||||
After | mHealth | 5 (14.2) | -0.32 | 0.744 | Face-to-Face | -3.27 | 0.001 | Â | ||
Face-to-Face | 6 (17.1) | Â | ||||||||
TG (mg/dl) | > 150 | Before | mHealth | 23 (65.7) | -0.24 | 0.804 | mHealth | -3.00 | 0.003 |  |
Face-to-Face | 22 (62.8) | Â | ||||||||
After | mHealth | 14 (40.0) | -2.38 | 0.017 | Face-to-Face | -0.70 | 0.480 | Â | ||
Face-to-Face | 24 (68.5) | Â | ||||||||
AL (g/dl) | < 3.5 | Before | mHealth | 8 (22.8) | 0.00 | 1.00 | mHealth | -2.33 | 0.020 |  |
Face-to-Face | 8 (22.8) | Â | ||||||||
After | mHealth | 1 (2.8) | -0.58 | 0.558 | Face-to-Face | -1.89 | 0.058 | Â | ||
Face-to-Face | 2 (5.7) | Â | ||||||||
FER (µg/l) | < 30 and > 300 | Before | mHealth | 23 (65.7) | -0.96 | 0.333 | mHealth | -2.00 | 0.046 |  |
Face-to-Face | 19 (54.2) | Â | ||||||||
After | mHealth | 15 (42.8) | -0.95 | 0.342 | Face-to-Face | 0.00 | 1.00 | Â | ||
Face-to-Face | 19 (54.2) | Â |